Resmed Inc. buy KeyCorp
Start price
21.04.25
/
50%
€183.80
Target price
21.04.26
€234.41
Performance (%)
2.18%
End price
22.04.26
€187.80
Summary
This prediction ended on 22.04.26 with a price of €187.80. With a performance of 2.18%, the BUY prediction by KeyCorp for Resmed Inc. closed with a slight gain. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 7.264% | 7.264% | -25.525% |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at KeyCorp from $280.00 to $269.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten